Free Newsletter
Whistleblowers allege problems with Wyeth's Prevnar
Two former Wyeth workers continue to cause controversy for Wyeth's blockbuster vaccine Prevnar. Wyeth disclosed recently that the workers'Â whistleblower suits accused the company of making false statements to the government concerning manufacturing problems with the vaccine.
Anthony Sokol, a manufacturing scientist, says he was fired after raising concerns regarding the vaccine and that Wyeth had concealed and misrepresented the data it gave to the government. Sokol's suit alleges he was fired in 2005. Prevnar earned $2.4 billion in sales last year.
- read the report from the Wall Street Journal
Related Article:
Pharma execs practice positive thinking. Report
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities


SHARE
WITH: